KalVista Pharmaceuticals
KALV
KALV
75 hedge funds and large institutions have $328M invested in KalVista Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
+7
Holders Change %
+10.29%
% of All Funds
1.63%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.09%
New
24
Increased
20
Reduced
18
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BlackRock
New York
|
+$14.8M |
2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$13.3M |
3 |
DM
Deerfield Management
New York
|
+$12.6M |
4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$10.1M |
5 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$5.35M |
Top Sellers
1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$41.2M |
2 |
VMI
VHCP Management III
New York
|
-$7.37M |
3 |
Renaissance Technologies
New York
|
-$4.58M |
4 |
VMI
VHCP Management II
New York
|
-$4.35M |
5 |
O
OrbiMed
New York
|
-$2.59M |